Dr Reddys Laboratories (RDY) pipeline and stated timing

abatacept biosimilar: in mid-December 2026 · Filed Jul 29, 2026

Name in SEC filings: DR REDDYS LABORATORIES LTD

RDY · 1 program · Latest stated timing: “in mid-December 2026” · No timing wording changes on record.

Pipeline at a glance

Program	Event	Stage	Stated timing	Filing
abatacept biosimilar	FDA goal date (company stated)	Stage not stated	in mid-December 2026	6-K · Jul 29, 2026

Source: ORION, orionbiotechai.com/company/RDY, data as of Oct 29, 2026
https://www.orionbiotechai.com/company/RDY

Latest retained statement: abatacept biosimilar · FDA goal date (company stated) · in mid-December 2026 · 6-K filed Jul 29, 2026

SEC sources last checked Oct 29, 2026.

No full company check on record. The date above is the newest check of a single row.

Programs and stated timing

○ Quote matched to filing (not yet reviewed by founder) · ✓ Checked by founder.

abatacept biosimilar

not stated in the cited filing

Quote matches the filing

FDA goal date (company stated)in mid-December 2026

Stage: Not stated

Public float: Unknown (no public float found in SEC filings).

As we speak today, the goal date for abatacept is in mid-December 2026.

6-K · Filed Jul 29, 2026 · Source rechecked Oct 29, 2026

founder confirmed 2026-10-30

Source details

Accession 0001575872-26-000536

SEC accepted the filing Jul 28, 2026, 9:17:22 PM ET

Timing wording over time

Dots are filing dates. Bars show resolved calendar periods; timing wording stays as stated.

Sources: EX-99.1 filed Jul 29, 2026.

Calendar: same stage

How this date was described over time

Company periods and sentences are quoted as written. A matching disclosure uses the SEC filing date for the same program and event type. As of Oct 30, 2026.

Program / event

Stated period and SEC wording

Disclosure in stated period

abatacept biosimilarOther

in mid-December 2026

“As we speak today, the goal date for abatacept is in mid-December 2026.”

Filed Jul 29, 2026 · EX-99.1

Not compared

ORION has no confirmed start and end dates for this wording, so it is not compared with filings.

“Not compared” means ORION has not matched this wording against a complete set of SEC filings for its period. It says nothing either way about whether a matching filing exists. Wording without exact dates is not given calendar dates.

Request another SEC timing statement

Suggest an SEC timing statement to add for RDY. You can include the original filing link in your note. The founder reads each request by hand.

Or email ORION.

Reading these records

First stated window: The timing wording in the earliest company statement located within the sources checked, quoted as written (for example “2H 2026”). An earlier statement may exist outside those sources.
Disclosure date: The date of the filing or company release that disclosed the readout. “None found” means no such disclosure was located in the sources checked. SEC filings were searched through the “SEC filings searched through” date shown.
1H, 2H, 1Q–4Q: First or second half, or first to fourth quarter, of the year named, as the company wrote it. Equivalent notations are compared together; the original wording stays visible.
SEC original: The filing as published on the SEC EDGAR system. “Company original” is the release on the company's own investor site.
Status: One of seven labels set by founder review of the original filings. Definitions: Methodology.

See RDY in the calendar · Review labels and methodology